News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
CEO of Agenus, Garo Armen shares details on our royalty financing agreement with Ligand Pharmaceuticals
Photo taken from Agenus/LinkedIn
May 12, 2024, 03:08

CEO of Agenus, Garo Armen shares details on our royalty financing agreement with Ligand Pharmaceuticals

Agenus shared on LinkedIn:

“‘With this infusion of capital, we are poised to accelerate the development of our lead therapeutic combination regimen, botensilimab/balstilimab, which we expect to make a significant impact in the treatment of MSS colorectal cancer.

This initiative brings us closer to our goal of dramatically improving cancer treatment for patients who are often left with limited or no options.’

Chairman and CEO Garo Armen shares details on our royalty financing agreement with Ligand Pharmaceuticals.”

Additional information.
Source: Agenus/LinkedIn

 

Agenus Balstilimab botensilimab cancer colorectal cancer Garo Armen Ligand Pharmaceuticals OncoDaily Oncology
Special Coverage
New Paper Alert
Aug 14, 2025, 00:38
Survival Benefit of High TMB and BRAF Mutation in Advanced Melanoma on Adjuvant Anti–PD-1
Insight
Aug 13, 2025, 21:09
Elisa Agostinetto: Patients’ and Physicians’ Perspectives on Brain Imaging Screening in Metastatic Breast Cancer
Insight
Aug 13, 2025, 21:09
Amir Manbachi: Fighting Glioblastoma with Sound Waves
Voices
Aug 13, 2025, 20:52
Chiara Corti: Ranking Oncologists in Social Media - What Could Go Wrong?
Insight
Aug 13, 2025, 20:36
Talha Badar: Brief Thread on Clonal Hematopoiesis
Voices
Aug 13, 2025, 20:35
Ethical, Legal, and Governance Challenges of Digitalising Oncology Care - European Health Management Association
Voices
Aug 13, 2025, 20:22
Stephen V Liu: Cataloging Success - Repotrectinib's Efficacy in a ROS1 NSCLC Resistance Case
Opinion
Aug 13, 2025, 20:15
Tom Powles: Opening a New Area for Cis-Ineligible MIBC
Voices
Aug 13, 2025, 19:46
Mario Balsa: ESMO Guidelines for Localized Rectal Cancer Are Here
Science
Aug 13, 2025, 19:37
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers
Science
Aug 13, 2025, 19:21
Naveen Pemmaraju: Prognostic Impact of NPM1 Co-Mutation in FLT3-Mutated AML
Voices
Aug 13, 2025, 19:12
Narjust Florez: Are Women More Affected by Lung Cancer Surgery?